* Sabra Health Care REIT Inc is expected to show a rise in quarterly revenue when it reports results on October 31 for the period ending September 30 2024

* The Irvine California-based company is expected to report a 6.6% increase in revenue to $172.34 million from $161.63 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data. (SAL Represents Rental revenue/ Total revenue)

* ​LSEG's mean analyst estimate for Sabra Health Care REIT Inc is for earnings of 16 cents per share.

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months. ​

* Wall Street's median 12-month price target for Sabra Health Care REIT Inc is $20.00​, above​ its last closing price of $19.27. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT ESTIMATE MET, SE %

E® MISSED

Jun. 30 2024 0.35 0.34 0.35 Beat 1.6

Jan. 1 2024 0.33 0.33 0.34 Beat 2.7

Dec. 31 2023 0.33 0.33 0.32 Missed -3.2​

Sep. 30 2023 0.33 0.33 0.33 Met -0.8

​​Jun. 0.33 0.33 0.33 Met -1.3

30 2023

Mar. 31 2023 0.34 0.34 0.33 Missed -4​

Dec. 31 2022 0.35 0.36 0.37 Beat 4.1

Jan. 1 0001 0.37 0.37 0.36 Missed -3.2

This summary was machine generated October 30 at 08:03 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)